Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Frontiers in Immunology
|
August 28, 2020
Adoptive Cell Transfer of Regulatory T Cells Exacerbates Hepatic Steatosis in High-Fat High-Fructose Diet-Fed Mice
Mikhaïl A Van Herck, Luisa Vonghia, Wilhelmus J Kwanten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 19, 2025
Biomarkers of Histological Response in Lanifibranor-treated Patients With Metabolic Dysfunction-associated Steatohepatitis
Jérôme Boursier, Hugo Hervé, Marine Roux, et al.
Frontiers in Molecular Medicine
|
August 1, 2024
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)
Claudia Theys, Tineke Vanderhaeghen, Evelien Van Dijck, et al.
Nature Communications
|
May 10, 2024
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis
Michael P Cooreman, Javed Butler, Robert P Giugliano, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
August 13, 2016
Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice
Wilhelmus J Kwanten, Yves-Paul Vandewynckel, Wim Martinet, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
May 4, 2020
Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis
Mikhaïl A Van Herck, Luisa Vonghia, Wilhelmus J Kwanten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 11, 2024
Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma
Jesús Rivera-Esteban, Sergio Muñoz-Martínez, Mónica Higuera, et al.
Frontiers in Pharmacology
|
July 12, 2021
The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer Model
Hanne Van Spaendonk, Hannah Ceuleers, Annemieke Smet, et al.
Virchows Archiv : an International Journal of Pathology
|
January 26, 2023
Zonated quantification of immunohistochemistry in normal and steatotic livers
Cédric Peleman, Winnok H De Vos, Isabel Pintelon, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 13, 2018
Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats
Denise Van der Graaff, Wilhelmus J Kwanten, Filip J Couturier, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Frontiers in Immunology
|
August 28, 2020
Adoptive Cell Transfer of Regulatory T Cells Exacerbates Hepatic Steatosis in High-Fat High-Fructose Diet-Fed Mice
Mikhaïl A Van Herck, Luisa Vonghia, Wilhelmus J Kwanten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 19, 2025
Biomarkers of Histological Response in Lanifibranor-treated Patients With Metabolic Dysfunction-associated Steatohepatitis
Jérôme Boursier, Hugo Hervé, Marine Roux, et al.
Frontiers in Molecular Medicine
|
August 1, 2024
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)
Claudia Theys, Tineke Vanderhaeghen, Evelien Van Dijck, et al.
Nature Communications
|
May 10, 2024
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis
Michael P Cooreman, Javed Butler, Robert P Giugliano, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
August 13, 2016
Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice
Wilhelmus J Kwanten, Yves-Paul Vandewynckel, Wim Martinet, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
May 4, 2020
Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis
Mikhaïl A Van Herck, Luisa Vonghia, Wilhelmus J Kwanten, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 11, 2024
Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma
Jesús Rivera-Esteban, Sergio Muñoz-Martínez, Mónica Higuera, et al.
Frontiers in Pharmacology
|
July 12, 2021
The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer Model
Hanne Van Spaendonk, Hannah Ceuleers, Annemieke Smet, et al.
Virchows Archiv : an International Journal of Pathology
|
January 26, 2023
Zonated quantification of immunohistochemistry in normal and steatotic livers
Cédric Peleman, Winnok H De Vos, Isabel Pintelon, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
January 13, 2018
Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats
Denise Van der Graaff, Wilhelmus J Kwanten, Filip J Couturier, et al.
Page
of 6